Related Experiment Video
Updated: Jul 6, 2026
06:54
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Tetraspanin in oncogenic epithelial-mesenchymal transition
Ruth J Muschel1, Annamaria Gal
1Radiation Oncology and Biology, The Radiobiology Research Institute, University of Oxford, Oxford, United Kingdom. ruth.muschel@rob.ox.ac.uk
The Journal of Clinical Investigation
|March 22, 2008
Summary
Overexpression of TM4SF5, a tetraspanin protein, drives cancer progression by inducing epithelial-mesenchymal transition (EMT) in liver cancer cells. This study provides the first evidence linking TM4SF5 to oncogenic EMT pathways and tumor formation.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Tetraspanin superfamily members, including the L6 family, are frequently overexpressed in various cancer types.
- The specific oncogenic role of L6 family members, particularly TM4SF5, in driving cancer progression has remained largely uncharacterized.
- Epithelial-mesenchymal transition (EMT) is a critical process in cancer metastasis and progression, but its direct molecular drivers are still being elucidated.
Discussion:
- This study investigates the role of TM4SF5 in hepatocellular carcinoma (HCC) and its potential involvement in EMT.
- The research explores how TM4SF5 overexpression in HCC cells alters cellular phenotypes.
- The findings suggest TM4SF5 may play a significant role in the oncogenic pathways associated with EMT.
Key Insights:
- Overexpression of TM4SF5 in human hepatocellular carcinoma cells induces phenotypic changes consistent with epithelial-mesenchymal transition (EMT).
- TM4SF5-induced EMT characteristics were observed, alongside unique aspects not typically described in classical EMT.
- The study demonstrates that TM4SF5-mediated cellular changes promote tumor formation when these modified cells are xenografted into mice.
Outlook:
- This research implicates TM4SF5 as a novel factor in EMT-driven cancer progression, particularly in hepatocellular carcinoma.
- Further investigation into TM4SF5's precise molecular mechanisms in EMT and its broader role across different cancer types is warranted.
- Targeting TM4SF5 could represent a potential therapeutic strategy for inhibiting cancer progression and metastasis.
Related Concept Videos
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:19Cadherins in Tissue Organization
The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
Cell Sorting During Development
Cell sorting plays an...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
01:35Cancer Cell Migration through Invadopodia
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...